Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of long-term simvastatin discontinuation.
Puccetti L, Scarpini F, Cappellone R, Auteri A. Puccetti L, et al. Among authors: scarpini f. Lancet. 2012 May 5;379(9827):1704; author reply 1704. doi: 10.1016/S0140-6736(12)60719-3. Lancet. 2012. PMID: 22559898 No abstract available.
Role of genetic factors in statins side-effects.
Scarpini F, Cappellone R, Auteri A, Puccetti L. Scarpini F, et al. Cardiovasc Hematol Disord Drug Targets. 2012 Sep;12(1):35-43. doi: 10.2174/187152912801823138. Cardiovasc Hematol Disord Drug Targets. 2012. PMID: 22524173
Genetic influence in statin intolerance.
Puccetti L, Scarpini F, Cappellone R, Auteri A. Puccetti L, et al. Among authors: scarpini f. Clin Pharmacol Ther. 2011 Sep;90(3):365. doi: 10.1038/clpt.2011.114. Epub 2011 Jul 13. Clin Pharmacol Ther. 2011. PMID: 21753748 No abstract available.
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.
Puccetti L, Santilli F, Pasqui AL, Lattanzio S, Liani R, Ciani F, Ferrante E, Ciabattoni G, Scarpini F, Ghezzi A, Auteri A, Davì G. Puccetti L, et al. Among authors: scarpini f. Atherosclerosis. 2011 Jan;214(1):122-8. doi: 10.1016/j.atherosclerosis.2010.10.006. Epub 2010 Nov 5. Atherosclerosis. 2011. PMID: 21056418 Clinical Trial.
Genetic influence in liver steatosis prevalence and proatherothrombotic/inflammatory profile in familial combined hyperlipoproteinemia.
Santilli F, Blardi P, Scarpini F, Acciavatti A, Ceccatelli L, Magliocca A, Avolio T, Bocchia M, Scapellato C, Gioffrè WR, Auteri A, Ferracane SC, Puccetti L. Santilli F, et al. Among authors: scarpini f. Int J Cardiol. 2013 Sep 20;168(1):536-9. doi: 10.1016/j.ijcard.2013.01.250. Epub 2013 Mar 7. Int J Cardiol. 2013. PMID: 23465229 No abstract available.
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome.
Santilli F, Blardi P, Scapellato C, Bocchia M, Guazzi G, Terzuoli L, Tabucchi A, Silvietti A, Lucani B, Gioffrè WR, Scarpini F, Fazio F, Davì G, Puccetti L. Santilli F, et al. Among authors: scarpini f. Vascul Pharmacol. 2015 Sep;72:16-24. doi: 10.1016/j.vph.2015.04.004. Epub 2015 Jun 25. Vascul Pharmacol. 2015. PMID: 26117210
15 results